• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


3.6200 USD 0.1100 3.13%

As of 17:15:06 ET on 12/24/2014.

Snapshot for BioTime Inc (BTX)

Open: 3.5600 Day's Range: 3.5100 - 3.6700 Volume: 118,751
Previous Close: 3.5100 52wk Range: 2.2100 - 4.1400 1-Yr Rtn: +3.43%

Stock Chart for BTX

No chart data available.
  • BTX:US 3.6200
  • 1D
  • 1M
  • 1Y
Interactive BTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.5699
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 300.90
Shares Outstanding (M) 83.12
30 Day Average Volume 193,179
Price/Book (mrq) 33.0442
Price/Sale (ttm) 41.3769
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BTX

BioTime, Inc. researches and develops synthetic solutions that can be used as blood plasma volume expanders, blood replacement solutions during hypothermic surgery, and organ preservation solutions. The Company also operates in regenerative medicine sector, where it develops stem cell related products and technology for diagnostic, therapeutic and research use.

Michael D WestChief Executive OfficerWilliam P TewChief Commercial Officer
Lesley A StolzExec VP:Corporate DevelopmentRobert W PeabodySenior VP/CFO/COO
More Company Profile & Key Executives for BTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil